Crony Dentistry Once Again Puts Children at Risk

Crony Dentistry Once Again Puts Children at Risk

Medical device companies appear to be trying to buy dentists, exposing children to high levels of unnecessary radiation. The New York Times ran a story a few years ago illustrating the extent to which cronyism (showing partiality to long-standing friends for mutual financial benefit, rather than following good science) determines medical care—in this instance, dental […]

Read More
Sneak Attack on Supplements, Slipped into Defense Bill—Stopped in Its Tracks!

Sneak Attack on Supplements, Slipped into Defense Bill—Stopped in Its Tracks!

Your messages to Capitol Hill accomplished this. But Sen. Durbin reportedly plans to reintroduce his usual anti-supplement bill soon. Earlier this summer, we alerted you to the latest under-the-radar attack on supplements perpetrated by Sen. Dick Durbin (D-IL) and his allies. This time, they tried to attach their amendments, which would have limited supplement usage […]

Read More
Coca-Cola Subverts Science

Coca-Cola Subverts Science

Crony science is on full display in the new partnership between the giant beverage company and a nonprofit looking to exonerate junk food in the obesity debate. The New York Times reports that Coca-Cola is pouring millions of dollars into a nonprofit organization that is trying to promote a peculiar solution to the obesity crisis. […]

Read More
FDA On Sugar: Not So Sweet

FDA On Sugar: Not So Sweet

The agency reverses itself—and capitulates to the sugar lobby. Action Alert! Recently, the FDA announced a proposal to include a daily recommended value (DRV) for added sugars on the Nutrition Facts label of packaged foods and dietary supplements. The “added sugars” designation has nothing to do with the amount of sugar that already occurs naturally […]

Read More
Three New FDA-Approved Diabetes Drugs May Cause Diabetic Comas

Three New FDA-Approved Diabetes Drugs May Cause Diabetic Comas

However, there are good natural approaches to managing or even curing some forms of diabetes. The FDA recently posted a warning that three drugs used to treat type 2 diabetes—canagliflozin (brand name: Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance)—may lead to diabetic ketoacidosis, or DKA. Ketoacidosis is a condition that can lead to diabetic coma and even death. […]

Read More